IL-4 and IL-5 levels decreased in the BALF and OVA-specific IgE in the serum from OVA-sensitized/challenged mice after irradiation. by Joong Sun Kim (828870)

A summary of the included study characteristics. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

IgA is decreased in individual donor milk and is present in human milk-based fortifiers. by Christian Tamar (21100605)

Overexpression of TbIF1 significantly affects the viability of BF and Dk cells due to the dramatic decrease of the Δψ_m when F_oF₁-ATPase is inhibite... by Brian Panicucci (177311)

Rab27A deficiency caused decreased amylase release from isolated acini. by Yanan Hou (736195)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Effect of 5-HTR blockade on cost-based motivation. by Yukiko Hori (299784)

TM4SF18-silencing decreases pancreatic cancer cell growth. by Megha Singhal (6494645)

“…B) Colorimetric MTT assay showing a decrease in cell viability in response to five days post-induction of TM4SF18 shRNA or control shRNA. …”

Heatmap representing exosomal proteins identified in A549 in order of decreasing levels in TRs (R1-R2-R3, R4-R5-R6, R7-R8-R9) and in BRs (R1-R4-R7, R2-R5-R6, R3-R6-R9). by Suma Tiruvayipati (3453497)

17β-estradiol (E₂) combined with anti-AGE treatment pyridoxamine (Pyr) increases ER and decreases TGF mRNA in glomeruli of aged ovariectomized female mice. by Simone Pereira-Simon (325005)

Data underlying Figs 1B, 1C, 1E, 1J, 1K, 2B, 2C, 2E, 2F, 2H, 2I, 3B, 3C, 3D, 3E, 3F, 4B, 4D, 4E, 4F, 4G, 5A, 5B, 6E and 6G. by Xinxin Li (281237)

<i>Bmp6</i> and <i>Hamp1</i> expression decreases in the livers of <i>Fpn1^Alb/Alb</i> mice with high iron demand. by Zhuzhen Zhang (311660)

<i>Fpn1^Tek/Tek</i> mice have liver iron loading but decreased <i>Bmp6</i> and <i>Hamp1</i> expression. by Zhuzhen Zhang (311660)

Dose-dependent increase in NREM sleep and decrease in wakefulness by <i>p</i>.<i>o</i>. administration of TEG in mice. by Mahesh K. Kaushik (3753871)

“…All administrations were done at the onset of dark period (17:00 h). Data presented as mean ± SEM; n = 6; *p≤0.05, **p≤0.01 vs vehicle by using paired t-test for time course data (C, D and E), and one-way ANOVA followed by least square difference (LSD) post-hoc test for dose-response data (F and G). # #p≤0.01 vs TEG (10 mg/head).…”

Decrease of cell viability and alterations of cell membrane permeability by infection with rotavirus isolates. by Carlos A. Guerrero (1264551)

Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

“…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”

Archazolid decreases the activity and expression of cathepsin B in endothelial cells. by Betty Luong (5738027)

Relative decreases in VP mean weights using -DDE against TP controls in nine laboratories (Lab) by William Owens (20777)

Relative decreases in VP mean weights using VIN against TP controls in eight laboratories (Lab) by William Owens (20777)

Wnt signaling decreases the expression of Tcf3 and increases that of Tcf1 and Lef1 containing β-catenin binding domain. by Atsushi Kuwahara (565069)